Team members from the Trinity College Dublin brain tumour project. Image: Trinity College Dublin
Among the projects receiving funding are studies on bone cancers and on the prevention of hospital-acquired infections from medical devices.
Under the Research Ireland Frontiers for the Future programme, 22 high-risk, high-reward research projects will each receive a share of €20m. The initiative aims to give innovators and independent investigators the chance to pursue their research, with the potential for breakthrough discoveries across health, tech and sustainability.
“The 22 projects announced today under Research Ireland’s Frontiers for the Future programme are ambitious in both scope and scale, spanning areas from pioneering cancer therapies to advancing a more sustainable and circular economy, and much more besides,” said the Minister for Further and Higher Education, Research, Innovation and Skills, James Lawless, TD.
Among the funded projects is GlycoMetalGuard, which is a study into glycoconjugate metal complexes as targeted bacterial therapeutics and protective coatings suitable for medical devices. Led by Dr Joseph Byrne at University College Dublin, the team is exploring how innovative antimicrobial coatings and therapies can prevent hospital-acquired infections stemming from medical devices, improving patient safety and quality of life.
